GlassScriptPhysician profile
Ziad A Katrib
NPI 1124327507
$7,181.46
in general payments reported to CMS, 2019-2025
17 companies · $2,253 in 2025
The $2,253 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $100 · 2021: $387 · 2022: $541 · 2023: $909 · 2024: $2,571 · 2025: $2,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,216 · Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,216.00 |
| Food and Beverage | $1,516.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $4,216.00 | 2024-2025 | |
| Stryker Corporation | $630.33 | 2019-2022 | |
| Axogen | $335.14 | 2019-2022 | |
| Integra Lifesciences Corporation | $267.95 | 2021-2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Smith+Nephew, INC. | $255.03 | 2023-2024 | Stravix, Oasis, Grafix Pl |
| Medtronic, INC. | $182.01 | 2023 | Propel |
| Zimmer Biomet Holdings, INC. | $145.31 | 2025 | Traumaone |
| Misonix INC | $145.26 | 2019 | |
| Abbvie INC. | $143.70 | 2023 | |
| Checkpoint Surgical, INC | $129.26 | 2023 | Checkpoint Stimulators |
| Regeneron Healthcare Solutions, INC. | $127.65 | 2024 | Dupixent |
| Osiris Therapeutics INC. | $122.91 | 2019 | |
| Inspire Medical Systems, INC. | $121.44 | 2023 | Inspire |
| Ambu INC. | $121.38 | 2023 | |
| Kls-Martin L.P. | $109.41 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $83.37 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $45.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Katrib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.